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Dobutamine has favorable properties for the pharmacologic ma-
nipulation of myocardial oxygen demand in the provocation of 
ischemia during the investigation of coronary artery disease. The 
value of dobutamine infusion for thallium myocardial perfusion 
tomography was assessed in 50 patients with exertional chest pain 
undergoing coronary arteriography. Dobutamine was infused in 
5-min stages at incremental rates from 5 to 20 p.g/kg per min or 
until limited by symptoms. The myocardium was divided into nine 
segments for analysis of perfusion. 
Thirty-nine of 40 patients with coronary artery disease had a 
reversible perfusion defect demonstrated by dobutamine thallium 
tomography (sensitivity 97%) and 8 of 10 patients with normal 
coronary arteries had normal myocardial perfusion (specificity 
80% ). These values were significantly better than the sensitivity 
and specificity of exercise electrocardiography (78% and 44%, 
respectively; p < 0.01). There was a significant relation between 
the mean number of segments with abnormal perfusion and the 
Patients with known or suspected coronary artery disease 
may undergo a variety of investigations. A history of typical 
angina confirmed by an abnormal electrocardiographic 
(ECG) response to exercise is often sufficient to make the 
diagnosis, but in selecting appropriate treatment, it is also 
important to assess the risk of future cardiac events. Thal-
lium myocardial perfusion imaging is especially valuable for 
the assessment of prognosis (I) and is superior to coronary 
angiography and exercise electrocardiography both before 
(2) and after (3) myocardial infarction. Because coronary 
arteriography does not provide a complete assessment of 
coronary artery function (4), myocardial perfusion imaging is 
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number of diseased coronary vessels (0.6, 2.6, 4.4 and 6 segments 
in zero-, one-, two- and three-vessel disease, respectively; p < 
0.001). There was also a significant relation between the maximal 
tolerated dose of dobutamine and the treadmill exercise time (r = 
0.56, p < 0.001), but a wide range of exercise times was achieved 
in the 15- and 20-~tg/kg per min groups, principally because of 
exercise limitation by noncardiac symptoms. Dobutamine infusion 
was well tolerated in all patients, including six with asthma. There 
were no significant arrhythmias or limiting symptoms other than 
chest pain. 
Dobutamine thallium myocardial perfusion tomography is a 
useful technique for the detection, localization and assessment of 
myocardial ischemia, particularly when exercise potential is lim· 
ited. Both the safety of dobutamine in asthmatic patients and the 
relation between achieved dose and exercise time represent advan· 
tages over the use of adenosine or dipyridamole. 
(JAm Coli Cardiol1991;18:1471-9) 
playing an increasingly important complementary role in the 
evaluation of coronary artery disease. 
Central to the assessment of myocardial perfusion is 
some form of intervention, usually dynamic exercise, but 
alternatives that demand less patient cooperation are attract-
ive, particularly when exercise is limited by noncardiac 
symptoms. The alternatives include beta-adrenergic agonists 
(dobutamine) (5), adenosine (6,7), vasoconstrictors (8), car-
diac pacing (9), isometric exercise (10) and cold pressor 
stress (11), but the greatest experience has been with dipyr-
idamole (12), which is now used routinely in some centers, 
often in combination with dynamic exercise (13,14). One 
problem with dipyridamole is that defects of thallium uptake 
may be associated with clinically manifest myocardial is-
chemia in only two thirds of cases (15) and thus it is difficult 
to be confident that perfusion defects are the same as those 
that are related to symptoms in everyday life. Furthermore, 
dipyridamole is not an ideal agent to use with other imaging 
techniques that require myocardial ischemia to detect abnor-
malities (16). Dobutamine does not suffer from this disad-
vantage and its short duration of action simplifies the control 
of myocardial ischemia during imaging. We report our 
experience of dobutamine coupled with thallium emission 
tomographic imaging in 50 patients with suspected coronary 
artery disease. 
0735-1097/91/$3.50 
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Methods 
Study patients. Fifty patients who were scheduled to 
undergo coronary angiography because of known or sus-
pected coronary artery disease were studied. Forty-two 
were male and the mean age was 54 years (range 36 to 75). 
All patients had a history of exertional chest pain, 15 (30%) 
had had a previous myocardial infarction and 36 (72%) 
had ST segment depression on the exercise ECG. Excluded 
from the study were patients with chest pain at rest, 
adverse reaction during conventional exercise testing, sys-
tolic blood pressure > 200 mm Hg or diastolic blood pressure 
> 100 mm Hg, known ventricular arrhythmias, second or 
third degree atrioventricular heart block, implanted pace-
maker, hypertrophic cardiomyopathy, valvular heart disease 
or heart failure of New York Heart Association class III or 
IV. Normal medication was continued except for beta-
adrenergic blockers, which were discontinued 48 h before 
the study. The study was approved by the local Ethical 
Committee and informed consent was obtained from each 
patient. The estimated radiation exposure to the patient from 
80 MBq of thallium is 25 mSv (17). 
Dobutamine stress test. The patients were supine and 
dobutamine was infused by an IV AC 711 syringe pump 
(IV AC Corp.) into a peripheral vein, starting at a rate of 
5 p,g/kg per min and increasing by 5 p,g/kg per min each 5 min 
to a maximum of 20 p,g/kg per min or until the occurrence of 
significant symptoms or signs. These were defined as chest 
pain of a severity that would normally require the use of 
sublingual nitroglycerin, any other intolerable symptom, 
sustained arrhythmia or hypertension (systolic pressure 
> 220 mm Hg, diastolic pressure > ll 0 mm Hg). Lead CM5 of 
the ECG was monitored and blood pressure was measured at 
each stage of the infusion. At the peak dobutamine infusion 
rate, 80 MBq of thallium was injected through a second 
intravenous cannula and the dobutamine was continued for a 
further minute. 
Imaging technique. Emission tomographic imaging was 
begun within 5 min of stopping the dobutamine infusion and 
redistribution imaging was performed 4 h later in an identical 
manner. A General Electric 400AZS gamma camera and a 
Star computer system were used. Thirty-two planar images 
(64 x 64 pixel matrix, 400-mm field of view, 30 s/image) were 
acquired over a 180° arc from the right anterior oblique to left 
posterior oblique position. The planar images were recon-
structed into transaxial tomograms of l-pixel depth using 
back projection and a Ramp-Hanning filter with a 0.75-
pixel-1 cutoff frequency. From these, oblique tomograms 
were reoriented in the vertical long-axis, horizontal long-axis 
and short-axis planes. 
Data analysis. The thallium tomograms were assessed by 
two experienced operators without knowledge of the coro-
nary anatomy. The heart was divided into nine segments 
corresponding to the basal and apical portions, respectively, 
of the anterior, inferior and lateral walls and septum, with a 
single segment at the apex (Fig. 1). Thallium uptake was 
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Figure 1. The myocardium was divided into nine segments for 
analysis of the apical and basal portions of the inferior, lateral and 
anterior walls and septum with a single apical segment. HLA = 
horizontal long-axis plane; SA = short-axis plane; VLA = vertical 
long-axis plane. 
classified in each segment as normal, mildly, moderately or 
severely reduced or absent. A reversible defect was one that 
improved by at least one category after redistribution and a 
fixed defect was one that was unchanged in both images. 
Differences in interpretation were resolved by consensus. 
Coronary angiograms in multiple projections were inter-
preted visually by the clinician in charge of the patient's care 
without knowledge of the thallium images. Significant dis-
ease was defined as a reduction of normal luminal diameter 
by 2:50% in a major vessel or its principal branches. An 
exercise ECG was performed with use of the Bruce protocol 
and an abnormal ST segment response was defined as 
> l-mm planar or downsloping ST segment depression 80 ms 
after the J point. 
Statistical analysis. McNemar's test for comparison of 
two proportions was used to analyze the difference between 
thallium tomography and the exercise ECG in the detection 
of coronary artery disease. One-way analysis of variance 
with repeated measures was used to compare the hemody-
namic data for the groups. Linear regression analysis was 
Table 1. Mean Hemodynamic Effects of Dobutamine at Each 
Stage of the Infusion 
Rate of Dobutamine Infusion (tLg/kg per min) 
0 5 10 15 20 
Systolic blood 135.5 152.1 157.8 158.4 162.4 
pressure (mm Hg) 
Diastolic blood 77.1 75.9 75.8 75.8 77 
pressure (mm Hg) 
Heart rate (beats/min) 71.7 84.2 96.6 112.3 120.5 
Rate-pressure product 9.7 12.8 15.2 17.8 19.6 
(mm Hg/min x 103) 
All variables except diastolic blood pressure show a significant increase 
with dobutamine (p < 0.001). 
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Table 2. Overall Sensitivity and Specificity of Dobutamine 
Thallium-201 Tomography in the Detection of Coronary 
Artery Disease 
Coronary Artery 
Disease 
Dobutamine Thallium-201 Myocardial Perfusion 
Tomography 
Present (n = 40) 
Absent (n = 10) 
Abnormal 
39 
2 
Normal 
8 
Sensitivity Specificity 
97% 
80% 
Thallium-201 tomography was significantly superior to exercise electro-
cardiography in the detection of coronary artery disease (p < 0.01). 
used to analyze the relation between the treadmill exercise 
times and the tolerated dobutamine dosage. The distribution 
of the number of ischemic thallium segments according to 
the number of diseased coronary arteries was analyzed by 
using the Spearman rank correlation coefficient. Probability 
values <0.05 were considered significant. 
Results 
Hemodynamic effects of dobutamine (Table 1). Each in-
crement in dobutamine infusion rate was associated with an 
increase in systolic blood pressure, heart rate and double 
(rate-pressure) product (all p < 0.001), but diastolic blood 
pressure did not change significantly. At the maximal infu-
sion rate of 20 J.Lg/kg per min, the rate-pressure product 
approximately doubled. 
Sensitivity of dobutamine thallium tomography (Tables 2 to 
5). Significant coronary artery disease was present in 40 
patients (80%) with one-, two- and three-vessel involvement 
in 14, 16 and 10 patients, respectively. The left main stem 
was involved in two patients. The stress thallium tomograms 
showed reversible ischemia in 39 of these patients (Table 2, 
Fig. 2), yielding an overall sensitivity of 97% for the detec-
tion of coronary artery disease. The one patient with coro-
nary artery disease who had a normal dobutamine thallium 
tomogram had relatively minor disease with an occluded 
nondominant left circumflex artery and a lesion of the 
diagonal branch of the left anterior descending artery. There 
was a significant relation between the number of diseased 
coronary arteries and the mean number of abnormal myo-
cardial segments (Spearman rank correlation coefficient [r5 ] 
Table 3. Correlation of Number of Diseased Vessels and 
Abnormal Thallium-201 Perfusion Segments 
No. of Abnormal Thallium-
No. of 
20 I Segments 
No. of Diseased Vessels Patients Mean SD Range 
0 10 0.6 1.3 0-4 
14 2.6 1.4 1-6 
2 16 4.4 2.1 0-7 
3 10 6 1.5 4-9 
The number of abnormal myocardial segments was significantly correlated 
with the number of diseased coronary vessels (p < 0.001). 
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Table 4. Sensitivity of Detection of Individual Coronary Artery 
Lesions According to the Detection of Ischemia in Predefined 
Myocardial Territories 
Dobutamine Thallium-201 Tomography 
No. of No. of Sensitivity 
Arterial Stenosis in Stenoses Territory Defects (%) 
Left main stem 2 Ant + lateral 2 100 
LAD 27 Ant or sept or ap 25 92 
RCA 24 Inferior 21 87 
LCx 25 Lateral 10 40 
Ant = anterior; ap = apical; LAD = left anterior descending coronary 
artery; LCx = left circumflex coronary artery; RCA = right coronary artery; 
sept = septal. 
= 0.76, p < 0.001), but the large range of number of ischemic 
segments in each group reflected the difference between the 
anatomic and functional assessment of the severity of the 
coronary artery disease (Table 3). Both patients with left 
main stem stenosis had reversible ischemia of the anterior 
and lateral walls. Twenty-five (92%) of 27 patients with 
disease of the left anterior descending coronary artery had 
reversible ischemia of the anterior wall, septum or apex. 
Twenty-one (87%) of 24 patients with right coronary artery 
disease had reversible ischemia of the inferior wall, but only 
10 (40%) of 25 patients with disease of the left circumflex 
coronary artery had a lateral wall defect (Table 4). 
Because a majority (n = 21) of the 25 patients with left 
circumflex artery lesions had reversible inferior wall ischem-
ia but only a minority (n = 10) had reversible lateral wall 
ischemia, we separately analyzed the patients with isolated 
disease of either the left circumflex (n = 12) or the right (n = 
11) coronary artery (Table 5). Inferior wall ischemia (50%) 
was more common than lateral wall ischemia (25%) in 
patients with isolated left circumflex artery lesions, but 
lateral wall ischemia was unusual (9%) in patients with an 
isolated right coronary artery lesion. If either the inferior or 
lateral wall is considered to be the territory of the left 
circumflex artery, then sensitivity for the detection of left 
circumflex artery disease in these patients was 83%. 
Fifteen patients had had a previous myocardial infarc-
tion, 12 with and 4 without Q waves (1 patient had a Q wave 
and a non-Q wave infarction in different territories). In 12 
patients with a Q wave infarction, 11 had a fixed defect of 
Table 5. Site of Perfusion Defect in 23 Patients With Either a Left 
Circumflex or a Right Coronary Artery Lesion but Not Both 
Site of Isolated 
Vessel No. of 
Site of Dobutamine Thallium-201 
Tomographic Defect 
Inferior 
and 
Stenosis Stenoses Inferior Lateral Apex Lateral 
LCx 12 6 3 I 
RCA 11 9 I 0 
Abbreviations as in Table 4. 
None 
I 
0 
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Figure 2. Thallium myocardial perfusion tomography using dobu-
tamine stress in a patient with three-vessel coronary artery disease. 
A, Band C, Stress images. D, E and F, Redistribution images. A and 
D, Vertical long-axis plane. B and E, Horizontal long-axis plane. 
C and F, Short-axis plane. There is reversible ischemia of the distal 
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anterior wall, septum and apex and lateral wall. There is a fixed 
perfusion defect of the inferior wall. The patient had inferior Q 
waves on the electrocardiogram, with a blocked proximal right 
coronary artery and proximal stenoses of the left circumflex and left 
anterior descending coronary arteries. 
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Table 6. Specificity of Dobutamine Thallium-201 Tomography for 
Individual Arterial Territories in 40 Patients 
Absence of Dobutamine Thallium-201 Tomography 
Stenosis in No. Territory Abnormality Specificity 
LAD 23 Ant, sept, ap 5 78% 
LCx/RCA 13 Inf, !at 3 76% 
Inf = Inferior; !at = lateral; other abbreviations as in Table 4. 
thallium uptake and 1 had a reversible defect. In four 
patients with a non-Q wave infarction, one had a fixed 
defect, two had a reversible defect and no defect was present 
in one patient who had had an anterior non-Q wave infarc-
tion but only hemodynamically insignificant atheromatous 
disease of the left anterior descending artery. No fixed defect 
was found in patients without a history of myocardial 
infarction. 
Specificity of dobutamine thallium tomography (Tables 2 to 
6). Eight of the 10 patients with angiographically normal 
coronary arteries had a normal thallium tomogram (specific-
ity 80%) (Table 2). Both patients with an abnormal thallium 
tomogram were subsequently classified by the supervising 
clinician as having syndrome X. One was a 58-year old 
woman who was limited by chest pain and dyspnea with 
2-mm ST depression in the lateral ECG leads after only 3 min 
of a standard Bruce protocol exercise test. Dobutamine 
thallium tomography showed anteroseptal reversible ischem-
ia (Fig. 3). The other patient, a 42-year old man, had an 
exercise time of 7 min that was limited by chest pain and 
dyspnea with 3 mm of inferolateral ST depression. Dobu-
tamine thallium tomography showed reversible anteroseptal 
ischemia. 
Five of 23 patients without significant stenosis of the left 
anterior descending coronary artery had an abnormal tomo-
gram suggesting reversible ischemia in the anterior wall, 
septum or apex (specificity for left anterior descending 
artery disease 78%) (Table 6). Two of the five had a stenosis 
that was judged to be 40%, one had a left anterior descending 
artery myocardial bridge and two had a diagnosis of syn-
drome X. Because of the difficulty in assigning an exclusive 
territory to the left circumflex artery, this artery was con-
sidered together with the right coronary artery. Three of 13 
patients without significant stenosis of either the right or left 
circumflex coronary artery had an abnormal tomogram sug-
gesting reversible ischemia of either the inferior or the lateral 
wall (specificity for both right and left circumflex artery 
disease 76%) (Table 6). Two of these patients had severe 
ectasia of the right coronary artery; the third patient had an 
occluded large left anterior descending artery that supplied 
the inferior wall. 
Comparison of dobutamine thallium tomography and ex· 
ercise electrocardiography. Thirty-one of the 40 patients 
with coronary artery disease had an abnormal ST segment 
response during dynamic exercise suggestive of myocardial 
ischemia (sensitivity 78%). In the remaining nine patients 
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exercise was mainly limited by noncardiac symptoms: fa-
tigue in four and arthritis, claudication, dyspnea, chest pain 
and left bundle branch block in one patient each. 
Five of the 10 patients without coronary artery disease 
had an abnormal ST segment response to exercise and 1 had 
left bundle branch block (specificity 44%). Three of the four 
patients with a normal exercise ECG developed chest pain 
and one was limited by claudication. Dobutamine thallium 
myocardial perfusion tomography was significantly superior 
overall to the exercise ECG in the detection of coronary 
artery disease (p < 0.01). 
Figure 4 shows the relation between the treadmill exer-
cise time and the maximal dose of dobutamine that was 
tolerated. All patients are shown, but those who terminated 
exercise for reasons other than angina are distinguished from 
those who were limited by angina. A better correlation 
between dobutamine dose and exercise time would be ex-
pected in the latter group of patients and this was observed 
(all patients r == 0.32, p < 0.05; patients achieving maximal 
exercise r = 0.56, p < 0.001). Although the number of 
patients who tolerated only low doses of dobutamine is 
small, the relation to exercise time suggests that the dobu-
tamine dose could be used in the same way as exercise time 
to classify the severity of angina. 
Side effects of dobutamine. A dose of 5, 10, 15 and 
20 JLg/kg per min of dobutamine was tolerated by 50, 49, 44 
and 33 patients, respectively. The symptoms reported and 
signs observed during infusion are shown in Figure 5. Chest 
pain was the limiting symptom in 39 patients (78%), but 11 
(22%) achieved the maximal dose without pain. In one 
patient, dyspnea without chest pain was the limiting symp-
tom. Eight patients reported no chest pain or other side 
effects during the infusion. Some form of arrhythmia oc-
curred in 19 patients (38%); in 16 of these, ventricular 
premature beats were seen but were infrequent and not 
associated with hemodynamic disturbance. Atrial premature 
beats were seen in six patients, and sinus pauses, acceler-
ated nodal rhythm and left bundle branch block occurred in 
one patient each. The most common noncardiac side effects 
were skin tingling and flushing. Overall, the dobutamine 
infusion was well tolerated and many patients preferred it to 
dynamic exercise. 
Discussion 
Dobutamine has been used previously for the detection of 
coronary artery disease in combination with electrocardio-
graphy (5), echocardiography (18) and radionuclide ventric-
ulography (19). It has also been performed in combination 
with thallium myocardial perfusion imaging with use of a 
planar technique (20). Improvements in imaging hardware 
and software have led to a greater sensitivity and specificity 
for the detection of ischemia with tomographic imaging (21) 
and this is the first study to our knowledge to combine 
dobutamine stress with thallium myocardial perfusion to-
mography. 
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Figure 3. Thallium myocardial perfusion tomograms of a patient 
with syndrome X (normal epicardial coronary arteries) displayed in 
the same format as that in Figure 2. There is reversible ischemia of 
the anterior wall, septum and apex. 
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Figure 4. Relation between exercise time using the standard Bruce 
protocol and the maximal infusion dose of dobutamine that was 
tolerated. The solid squares represent exercise times in patients 
limited by angina. The open squares represent patients in whom 
exercise was not limited by cardiac symptoms. The line joins the 
mean exercise times of the patients who were limited by angina. 
Specificity and sensitivity. We demonstrated an overall 
sensitivity of 97% and a specificity of 80% for the detection 
of coronary artery disease with dobutamine thallium myo-
cardial perfusion tomography. This level of sensitivity is 
high, but such results might be expected in a group of 
patients who had extensive coronary artery disease and who 
were sufficiently symptomatic to be admitted for coronary 
arteriography. It is likely that the two patients with normal 
Figure 5. Side effects of dobutamine infusion in 50 patients. PB = 
premature beats. 
Chest Pain 39 No Chest Pain 11 
Non-Cardiac 28 
Pounding? Tingling 16 
Dyspnea 3 Flushing 6 
Arrhythmia 19 Nausea4 
Ventricular PB 16 Headache 3 
Atrial PB 6 Shaking 3 
other3 Ughtheaded 1 
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coronary arteries but abnormal scans who were diagnosed in 
retrospect to have syndrome X had true perfusion abnormal-
ities and that the tests were not falsely positive. Thallium 
defects are known to occur in this syndrome in the absence 
of epicardial coronary artery disease (22-24). For this rea-
son, we do not believe that sensitivity and specificity are 
good methods of assessing the accuracy of a functional 
technique such as thallium imaging because anatomic and 
functional data do not always agree. Nevertheless, the 
results do illustrate that dobutamine infusion is an excellent 
alternative to dynamic exercise in this group of patients. 
Comparison with exercise electrocardiography. The sen-
sitivity and specificity of exercise electrocardiography (78% 
and 44%, respectively) were not as high. The lower sensi-
tivity agrees with the results of many previous studies 
(25 ,26) comparin_g the exercise ECG and exercise thallium 
images and does not necessarily result from the different 
stress techniques used in this study. The low specificity is 
peculiar to the group of patients that we studied and is not 
representative of the exercise ECG in the general population 
of patients with stable angina. Because an abnormal or 
difficult exercise ECG may lead to referral for coronary 
arteriography, there is a strong pretest bias toward patients 
with a false positive ECG and hence a low specificity. 
Patients with disparity between thallium tomographic and 
coronary angiographic data. It is relevant to consider the 
five other patients in whom there was disparity between the 
results of thallium tomography and coronary angiography. 
Two patients had a reversible anterior perfusion defect with 
a left anterior descending lesion that was judged to be <50% 
diameter stenosis. In light of the variability of visual assess-
ment of coronary arteriograms, it is likely that the lesions in 
these patients were indeed hemodynamically significant. In 
one patient, a myocardial bridge constricted the left anterior 
descending artery in systole but not in diastole and the 
patient was therefore classified as not having significant 
disease. In fact, the association of myocardial bridging with 
a corresponding thallium defect has been reported previ-
ously (27 ,28). Two patients with an inferior wall defect in the 
absence of significant right coronary or left circumflex artery 
stenosis had a severely ectatic right coronary artery that may 
have limited coronary flow. These cases again emphasize the 
problems of comparing functional and anatomic tests. 
Relation between dobutamine dose and exercise time. In 
this study we demonstrated for the first time a relation 
between the maximal tolerated dobutamine dose and tread-
mill exercise performance in patients being assessed for 
coronary artery disease, although a relation was previously 
reported (29) between the maximal cardiac output achieved 
with dobutamine and dynamic exercise in patients with heart 
failure. The relation was fairly coarse because the patients 
who tolerated the two highest doses of dobutamine achieved 
a large range of exercise times. The patients might have been 
further stratified by use of higher doses, but we decided to 
limit our initial experience to more conventional doses. In 
addition, it was clear that it was possible to increase the 
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dobutamine dose to a maximum in patients whose exercise 
time had been limited by noncardiac problems or by techni-
cian intervention for significant ST segment changes without 
clinical symptoms. 
The relation between dobutamine dose and exercise time 
is clinically important because exercise time is often used as 
a measure of the severity of symptoms and is also an 
indicator of prognosis. Other agents such as dipyridamole 
and adenosine produce inequalities of perfusion and myo-
cardial ischemia by a mechanism different from that which 
occurs during dynamic exercise and a relation between dose 
and severity of symptoms has not been demonstrated. Al-
though we do not have sufficient experience to suggest that 
dobutamine should be used instead of dynamic exercise in all 
patients, the relation strengthens the case that it could be 
used in this way. 
Choice of beta-adrenergic agonist. The beta-sympathetic 
agonists increase myocardial oxygen demand by virtue of 
their inotropic and chronotropic actions. Epinephrine, nor-
epinephrine, isoproterenol, dopamine and dobutamine are 
the most commonly used agents, but they differ in a number 
of ways, including hemodynamic effect, arrhythmogenicity 
and route of administration. Epinephrine-induced myocar-
dial ischemia has been detected by echocardiography (30), 
but the drug is unsuitable for routine stress testing because 
its alpha-adrenergic agonism leads to venoconstriction and 
makes it unsuitable for administration into a peripheral vein. 
The same is true of norepinephrine and dopamine, although 
the latter produces less intense venoconstriction. Isoproter-
enol has pure beta-sympathetic effects, but it is maintained 
in a solution of pH 2 and is highly irritant. Only dobutamine 
can be given safely into small peripheral veins. Isoproterenol 
has been used successfully for the echocardiographic imag-
ing of ischemia (31), but it increases heart rate with no action 
on blood pressure and therefore has less effect on the 
rate-pressure product than does dobutamine. Dobutamine is 
less arrhythmogenic than the other beta-agonists in the 
ischemic heart (32-34) and is more effective than dopamine 
in causing wall motion abnormalities (35). It is therefore the 
beta-agonist of choice for the pharmacologic manipulation of 
myocardial oxygen demand. 
Dobutamine eft'ects. The plasma half-life of dobutamine is 
120 s, giving it a rapid onset and cessation of action that 
allow easy control of blood levels during imaging. The main 
action of dobutamine is to increase myocardial oxygen 
demand and, in the setting of acute ischemia, it has been 
shown to increase oxygen demand above availability (36). In 
addition, dobutamine has other effects that may provoke 
myocardial ischemia in patients with coronary artery dis-
ease. It dilates the distal coronary vessels, which leads to an 
increase in coronary flow (37 ,38) and a decrease in perfusion 
pressure distal to a coronary stenosis. Flow therefore be-
comes heterogeneous (39) and may be redirected to the 
subepicardium (40). In this respect, it is similar to adenosine 
and dipyridamole. It may also increase flow resistance at the 
site of a stenosis (40). 
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The most important limitation of dobutamine is that its 
action is competitively inhibited by beta-adrenergic blockers. 
Atenolol was the most commonly prescribed beta-blocker in 
our group of patients and this has a long plasma half-life of 6 to 
9 h. Because of the confounding effects of beta-blockers, our 
patients discontinued treatment 48 h before the scan (approx-
imately 5 half-lives). No clinical complications resulted, but a 
worsening of angina or rest pain is a theoretic possibility. One 
patient inadvertently continued beta-blocker therapy despite 
instructions. At 20 p.g!kg per min of dobutamine, very little 
change in heart rate or blood pressure had occurred and 
thallium tomography revealed no evidence of myocardial isch-
emia. After consenting to a repeat study in the absence of 
beta-blocker therapy, there was the expected change in rate-
pressure product with stress, and reversible ischemia was 
detected. It is possible that higher doses of dobutamine would 
compete with beta-blockade, but the safety of such a maneuver 
has not been established. 
Clinical role of dobutamine. We demonstrated the value 
of dobutamine during thallium myocardial perfusion tomog-
raphy, but its role in relation to that of dipyridamole or 
adenosine (6,7) remains to be established. Dobutamine was 
well tolerated by six patients with asthma in this study and 
thus would certainly be the agent of first choice in patients 
with a history ofbronchoconstriction, in whom dipyridamole 
and adenosine are contraindicated. It is also likely to be 
superior when combined with imaging techniques such as 
echocardiography, radionuclide ventriculography and nu-
clear magnetic resonance imaging (41) that require signifi-
cant myocardial ischemia to produce an abnormality of 
regional ventricular function. This advantage occurs because 
the main action of dipyridamole and adenosine is to increase 
coronary flow rather than oxygen demand so that thallium 
defects may occur as a result of flow heterogeneity alone 
without accompanying ischemia (7 ,42). In addition, dobu-
tamine causes hyperkinesia of normal areas, an effect that 
accentuates the contrast with the hypokinesia or akinesia of 
abnormal areas (43), making it particularly suitable for wall 
motion studies. An advantage shared by dobutamine and 
adenosine is the short plasma half-life of each, which allows 
plasma levels to be maintained by constant infusion for 
operator-defined duration of stress. This ability is essential 
for radionuclide ventriculography and nuclear magnetic res-
onance imaging, although it may be less important for 
echocardiography. 
We are grateful to Victor Aber, Royal Brompton Hospital, for statistical 
advice and Dr. Gordon Coutes of Eli Lilly. We also thank the staff of the 
Institute of Nuclear Medicine for their contributions. 
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